Ads
related to: Enbrel- Is RINVOQ Right For You?
RINVOQ® Could Be Right For You.
See RINVOQ® Clinical Trial Results.
- Watch Video
What Is RINVOQ®?
Watch A Video To Learn More.
- Treatment Didn't Help?
Looking To Change Treatments?
RINVOQ® Could Be The Right Fit.
- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- Register For More Info
Sign Up For More
Information About RINVOQ®.
- What Is RINVOQ®?
Learn About The FDA-Approved
Oral Pill.
- Is RINVOQ Right For You?
Search results
Colorado Is Trying to Cap a Drug’s Price. Big Pharma Has Other Plans
Rolling Stone via Yahoo News· 2 months agoA state board in Colorado is working to make history by becoming the first in the country to cap the...
Here's What is Driving Amgen (AMGN) Stock's Outperformance
Zacks via Yahoo Finance· 1 year agoAmgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the...
Amgen (AMGN) Up 6.3% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 2 years agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have added about...
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 4 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Zacks via Yahoo Finance· 1 year agoPfizer PFE reported fourth-quarter 2022 adjusted earnings per share of $1.14, which significantly...
Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoPfizer PFE will report third-quarter 2022 results on Nov 1, before market open. In the last reported...
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 3 months agoFor more than a century, American investors have looked to the Dow Jones Industrial Average...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 8 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
Reuters via Yahoo Finance· 2 years ago(Reuters) -Amgen Inc on Thursday agreed to buy ChemoCentryx Inc for $3.7 billion to gain access to a...